Insight into the Biological Activity of Zingiber officinale var. Amarum Extracts as Antioxidant and SARS-CoV-2 Inhibitor In-Silico
Vifta R.L., Yanti S., Susmayanti W., Suyudi S.D.
Abstract
Galley Proof Zingiber officinale var. Amarum (Ginger) is a medicinal spice of the Zingiberaceae family. Its medicinal value can be attributed to its secondary metabolites, such as flavonoids, terpenoids, gingerols, and shogaols, which posses potent antioxidant properties. This study aimed to evaluate the effect of extraction solvent on the total flavonoid content, and antioxidant activity of emprit ginger, and to determine the anti-SARS-CoV-2 activity of major compounds of ginger in silico. Emprit ginger was extracted by refluxing seperately with ethanol, ethyl acetate, and n-hexane. The extracts were tested for the presence of flavonoid, and the total flavonoid content was determined by the aluminium chloride colorimetric method. The antioxidant activity of the extracts was assessed using the 2,2’-azino-bis (3ethylbenzotiazolin)-6-sulfonic acid (ABTS) radical scavenging assay. Anti-SARS-CoV-2 activity of major phenolic and flavonoid compounds of ginger including catechin, epicatechin, rutin, naringenin, quercetin, gingerol, and zingiberol was determined in silico by molecular docking with SARS-CoV-2 main protease (Mpro). Emprit ginger extracts contained flavonoids with total flavonoid contents of 103.93 mgQE/g, 97.32 mgQE/g, and 81.5 mgQE/g for ethyl acetate, n-hexane, and ethanol extracts, respectively. The ethyl acetate extract had the highest antioxidant activity with IC50 value of 20.02 µg/mL. Emprit ginger ligands showed strong interactions with SARS-CoV-2 main protease (Mpro) with binding energies ranging from-4.80 to 9.90 kcal/mol. Gingerol and zingiberol exhibited the most promising anti-SARS-CoV-2 activity in silico with binding energies of-4.80 and-5.30 kcal/mol. The study revealed emprit ginger as a source of natural antioxidant with promising anti-SARS-Cov-2 activity.
The effects of combination of Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients: A randomized controlled trial
Azizi N., Baghcheghi N., Esmaeili Saber S.S., Godazi M., Karimy M., Koohestani H.R., Mesri M., Montazer R., Roustaei Shirdel A.
Insights into the structural properties of SARS-CoV-2 main protease
Akbayrak I.Y., Caglayan S.I., Coskuner-Weber O., Kurgan L., Uversky V.N.
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Ahmed E.A., Al-kuraishy H.M., Alexiou A., Batiha G.E.-S., Hamad R.S., Papadakis M., Saad H.M.
In Silico Identification of New Anti-SARS-CoV-2 Main Protease (Mpro) Molecules with Pharmacokinetic Properties from Natural Sources Using Molecular Dynamics (MD) Simulations and Hierarchical Virtual Screening
Angwenyi D., Odhiambo P., Okoth P., Onyango H.
Profiling of insulin and resveratrol interaction using multi-spectroscopy and molecular docking study
Agrawal D.C., Chien W.-J., Yanti S.
Interaction between phloretin and insulin: a spectroscopic study
Agrawal D.C., Chien W.-J., Wu Z.-W., Yanti S.
Phytoconstituents of zingiber officinale targeting host-viral protein interaction at entry point of sars-COV-2: A molecular docking study
Chakotiya A.S., Sharma R.K.
Flavonoids are promising safe therapy against COVID-19
Al Joud S.M.A., Alkhayat F., Alzaabi M.M., Ashmawy N.S., El-Keblawy A.A., Hamdy R., Hamoda A.M., Khademi N.N., Soliman S.S.M.
Promising SARS-CoV-2 main protease inhibitor ligand-binding modes evaluated using LB-PaCS-MD/FMO
Boonyasuppayakorn S., Chavasiri W., Deetanya P., Harada R., Hengphasatporn K., Rungrotmongkol T., Shigeta Y., Sukandar E.R., Suroengrit A., Wangkanont K., Wilasluck P.
Functional bioactive compounds in ginger, turmeric, and garlic
Ademosun O.T., Ajanaku C.O., Ajanaku K.O., Ajayi S.O., Akinduti P.A., Atohengbe P.O., Obafemi Y.D., Owolabi O.A.